Clinical Trial Update: Study of Telcagepant (MK-0974) in Participants With Moderate to Severe Acute Migraine With or Without Aura (MK-0974-011) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for telcagepant (MK-0974) in adults with acute migraine, results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Telcagepant (telcagepant)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Migraine | Phase 3 | Status: COMPLETED | Results posted: 2014-08-04